NeuroVive announce results from CicloMulsion Phase I trial on cardiac ... News-Medical.net The mitochondrial medicine company NeuroVive Pharmaceutical today announces publication of the Phase I clinical study comparing CicloMulsion®, the Cremophor®-free intravenous cyclosporine formula (also known under the product name NeuroSTAT®) ... |
